Skip to main content

Published locations for Nintedanib and docetaxel provide small PFS advantage in NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nintedanib and docetaxel provide small PFS advantage in NSCLC

User login

  • Reset your password
  • /content/nintedanib-and-docetaxel-provide-small-pfs-advantage-nsclc
  • /oncologypractice/article/75972/lung-cancer/nintedanib-and-docetaxel-provide-small-pfs-advantage
  • /hematology-oncology/article/75972/lung-cancer/nintedanib-and-docetaxel-provide-small-pfs-advantage